Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 2
2005 4
2006 2
2007 5
2008 5
2009 4
2010 2
2011 8
2012 4
2013 4
2014 7
2015 6
2016 5
2017 3
2018 2
2019 6
2020 5
2021 7
2022 2
2023 7
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Results by year

Filters applied: . Clear all
Page 1
Molecular platforms for targeted drug delivery.
Maso K, Grigoletto A, Vicent MJ, Pasut G. Maso K, et al. Among authors: pasut g. Int Rev Cell Mol Biol. 2019;346:1-50. doi: 10.1016/bs.ircmb.2019.03.001. Epub 2019 Apr 9. Int Rev Cell Mol Biol. 2019. PMID: 31122392 Review.
Editorial: Highlights in nano-based drug delivery 2021/22.
Kumar S, Florindo HF, Pasut G. Kumar S, et al. Among authors: pasut g. Front Med Technol. 2023 Feb 24;5:1130414. doi: 10.3389/fmedt.2023.1130414. eCollection 2023. Front Med Technol. 2023. PMID: 36908293 Free PMC article. No abstract available.
Grand Challenges in Nano-Based Drug Delivery.
Pasut G. Pasut G. Front Med Technol. 2019 Dec 3;1:1. doi: 10.3389/fmedt.2019.00001. eCollection 2019. Front Med Technol. 2019. PMID: 35047870 Free PMC article. No abstract available.
Anti-HER2 Super Stealth Immunoliposomes for Targeted-Chemotherapy.
Canato E, Grigoletto A, Zanotto I, Tedeschini T, Campara B, Quaglio G, Toffoli G, Mandracchia D, Dinarello A, Tiso N, Argenton F, Sayaf K, Guido M, Gabbia D, De Martin S, Pasut G. Canato E, et al. Among authors: pasut g. Adv Healthc Mater. 2023 Nov;12(29):e2301650. doi: 10.1002/adhm.202301650. Epub 2023 Aug 30. Adv Healthc Mater. 2023. PMID: 37590033
CDCP1 overexpression drives prostate cancer progression and can be targeted in vivo.
Alajati A, D'Ambrosio M, Troiani M, Mosole S, Pellegrini L, Chen J, Revandkar A, Bolis M, Theurillat JP, Guccini I, Losa M, Calcinotto A, De Bernardis G, Pasquini E, D'Antuono R, Sharp A, Figueiredo I, Nava Rodrigues D, Welti J, Gil V, Yuan W, Vlajnic T, Bubendorf L, Chiorino G, Gnetti L, Torrano V, Carracedo A, Camplese L, Hirabayashi S, Canato E, Pasut G, Montopoli M, Rüschoff JH, Wild P, Moch H, De Bono J, Alimonti A. Alajati A, et al. Among authors: pasut g. J Clin Invest. 2020 May 1;130(5):2435-2450. doi: 10.1172/JCI131133. J Clin Invest. 2020. PMID: 32250342 Free PMC article.
Nanomedicines for the Delivery of Biologics.
Wahlich J, Desai A, Greco F, Hill K, Jones AT, Mrsny RJ, Pasut G, Perrie Y, Seib FP, Seymour LW, Uchegbu IF. Wahlich J, et al. Among authors: pasut g. Pharmaceutics. 2019 May 3;11(5):210. doi: 10.3390/pharmaceutics11050210. Pharmaceutics. 2019. PMID: 31058802 Free PMC article.
Thiol-Activated Anticancer Agents: The State of the Art.
Dalzoppo D, Di Paolo V, Calderan L, Pasut G, Rosato A, Caccuri AM, Quintieri L. Dalzoppo D, et al. Among authors: pasut g. Anticancer Agents Med Chem. 2017;17(1):4-20. Anticancer Agents Med Chem. 2017. PMID: 27539318 Review.
81 results